Acquiree Sapphire Biotech, Inc. Signs License Agreement to Exclusively License Patent Rights in Cancer Technology

Press/Media: Press / Media

PeriodJan 22 2020 → Jan 23 2020

Media coverage

3

Media coverage

  • TitleAXIM® Biotechnologies Acquiree Sapphire Biotech, Inc. Signs License Agreement to Exclusively License Patent Rights in Cancer Technology
    Media name/outletPharmaceutical Tech.com
    Country/TerritoryIndia
    Date1/23/20
    PersonsDouglas Lake
  • TitleAcquiree Sapphire Biotech, Inc. Signs License Agreement to Exclusively License Patent Rights in Cancer Technology
    Media name/outletMarket News Publishing
    Country/TerritoryUnited States
    Date1/22/20
    PersonsDouglas Lake
  • TitleAXIM® Biotechnologies Acquiree Sapphire Biotech, Inc. Signs License Agreement to Exclusively License Patent Rights in Cancer Technology
    Media name/outletPrimeNewswire (Top News)
    Country/TerritoryUnited States
    Date1/22/20
    PersonsDouglas Lake